Controversial issues in lymph node dissection of hilar cholangiocarcinoma

doi:10.3877/cma.j.issn.1674-3946.2019.06.001.

Abstract

Abstract:

The extent of lymph node dissection in hilar cholangiocarcinoma (HCCA) remain controversial. The dissection of No.8, 12 and 13 lymph nodes are generally recognized in clinical practice. However, there are still controversial issues such as necessity, exact extent, clinical significance and safety of expanded lymph node dissection for HCCA. All of above hot issues in HCCA treatment still need to be explored by further relevant clinical studies.

Key words: Bile duct neoplasms, Lymph node excision, Postoperative complications, Prognosis

Jian Wang, Min He. Controversial issues in lymph node dissection of hilar cholangiocarcinoma[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2019, 13(06): 541-545.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhpwkssxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3946.2019.06.001.

https://zhpwkssxzz.cma-cmc.com.cn/EN/Y2019/V13/I06/541

Figures/Tables 5

References 30

[1]	Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma：audit of 110 patients who underwent regional and paraaortic node dissection[J]. Ann Surg，2001，233(3): 385-392.
[2]	董家鸿，叶晟．不断提高肝门部胆管癌切除的精准化水平[J/CD]．中华普外科手术学杂志：电子版，2015，9(5): 1-4.
[3]	Aoba T, Ebata T, Yokoyama Y, et al. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes[J]. Ann Surg，2013，257(4): 718-725.
[4]	黄志强．肝门部胆管癌[J]．中华消化外科杂志，2013，12(3): 166-169.
[5]	Caplan I．Drainage lymphatique intra at extra－hepatic de la vessicule biliarie[J]．Bulletin Mein.Academia Medicale Belge，1982；137: 324-334.
[6]	Kurosaki I, Tsukada K, Hatakeyama K，et al.The mode of lymphatic spread in carcinoma of the bile duct[J]. Am J Surg，1996，172(3): 239-243.
[7]	Avril N, Rose CA, Schelling M，et al.Breast imaging with positron emission tomography and fluorine－18 fluonodeoxyglucose use and limitation[J]．J Clin Oncol，2008，18(20): 3495-3502.
[8]	Loschner C, Nagel SN, Kausche S，et al.Hepatic arterial supply in 1297CT－angiographies[J]．Rofo，2015，187(4): 276-282.
[9]	王坚．围肝门外科技术处理围肝门胆道肿瘤[J]．中华外科杂志，2018，56(5): 332-336.
[10]	王坚，陈炜．围肝门外科技术在胆道外科的应用[J]．中华消化外科杂志，2015，14(4): 284-287.
[11]	何敏，王昊陆，闫加艳，等．顺逆结合肝中裂劈开肝门显露法治疗Bismuth Ⅲ、Ⅳ型肝门胆管癌的安全性与疗效分析[J]．中华外科杂志，2018，56(5): 360-366.
[12]	陈炜，何敏，钱黎骏，等．顺逆结合肝门显露法取出肝内胆管金属支架[J]．中华消化外科杂志，2017，16(9): 973-975.
[13]	闫加艳，陈炜，王坚．顺逆结合肝门显露法治疗侵犯肝门的肝内胆管细胞癌[J]．中华消化外科杂志，2017，16(4): 417-422.
[14]	DeOliveria ML, Schulick RD, Nimura Y，et al.New Staging System and a Registryfor Perihilar Cholangiocarcinoma[J]．Hepatology，2011，53(4): 1363-1371.
[15]	Miyazaki M, Ohtsuka M, Miyakawa S，et al.Classification of biliary tract cancers established by the Japanese Society of Hepato－Biliary－Pancreatic Surgery: 3rd English edition[J]．J Hepatobiliary Pancreat Sci，2015，22(3): 181-196.
[16]	中华医学会外科学分会胆道外科学组，解放军全军肝胆外科专业委员会．肝门部胆管癌诊断和治疗指南(2013版) [J]．中华外科杂志，2013，51(10): 865-871.
[17]	Giuliante F, Ardito F, Guglielmi A，et al.Association of Lymph Node Status With Survival in Patients After Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis[J]．JAMA Surg，2016，151(10): 916-922.
[18]	Kambakamba P, Linecker M, Slankamenac K，et al.Lymph node dissection in resectable perihilar cholangiocarcinoma：a systematic review[J]. Am J Surg，2015，210(4): 694-701.
[19]	Hakeem AR, Marangoni G, Chapman SJ，et al.Dose the extent of lymphadenectomy，number of lymphnodes，positive lymph node ratio and neutrophil－lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? [J]．Eur J Gastroenterol Hepatol，2014，26(9): 1047-1054.
[20]	Murakami Y, Uemura K, Sudo T，et al.Prognostic factors after surgical resection for intrahepatic，hilar，and distal cholangiocarcinoma[J]．Ann Surg Oncol，2011，18(3): 651-658.
[21]	Su CH, Tsay SH, Wu CC, et al. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma[J]．Ann Surg，1996，223(4): 384-394.
[22]	Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma[J]. Ann Surg，1999，230(6): 808-818.
[23]	Tsao J, Nimura Y, Kamiya J, et al. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience[J]．Ann Surg，2000，232(2): 166-174.
[24]	Todoroki T, Kawamoto T, Koike N, et al. Radical resection of hilar bile duct carcinoma and predictors of survival[J]. Br J Surg，2000，87(3): 306-313.
[25]	Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors[J]. Ann Surg，1996，224(4): 463-473.
[26]	Pereira ER, Kedrin D, Seano G, et al. Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice[J]. Science，2018，359(6382): 1403-1407.
[27]	Brown M, Assen FP, Leithner A, et al. Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice[J]. Science，2018，359(6382): 1408-1411.
[28]	Schwarz RE, Smith DD.Lymph Node Dissection Impact on Staging and Survival of Extrahepatic Cholangiocarcinomas, Based on U．S. Population Data[J]. J Gastrointest Surg，2007，11(2): 158-165.
[29]	Mao K, Liu J, Sun J，et al.Patterns and Prognostic Value of Lymph Node Dissection for Resected Perihilar Cholangiocarcinoma[J]．J Gastroenterol Hepatol，2016，31(2): 417-426.
[30]	Ito K, Ito H, Allen PJ，et al.Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma[J]．Ann Surg，2010，251(4): 675-681.

Please choose a citation manager

Content to export